WCM
IDXX icon

Wealthcare Capital Management’s Idexx Laboratories IDXX Stock Holding History

Wealthcare Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-9
Closed -$4K – 347
2021
Q1 		$4K Buy
+9
New +$4.51K ﹤0.01% 430
2020
Q1 		– Sell
-9
Closed -$2K – 442
2019
Q4 		$2K Buy
+9
New +$2.37K ﹤0.01% 479

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wealthcare Capital Management's IDXX Position: Q2 2021 in Review

Wealthcare Capital Management sold out of Idexx Laboratories (IDXX) in Q2 2021, closing a stake of 9 shares — an estimated $4K sold.

Wealthcare Capital Management first reported a position in IDXX in Q4 2019 and held it in 2 quarters. The position peaked at $4K in Q1 2021. 1,034 funds tracked by Wall St. Rank hold IDXX as of Q2 2021.

  • Wealthcare Capital Management reported no remaining Idexx Laboratories position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Capital Management sold 9 Idexx Laboratories shares in Q2 2021, an estimated $4K.
  • Wealthcare Capital Management first reported a position in Idexx Laboratories in Q4 2019 and held it in 2 quarters.
  • Wealthcare Capital Management's Idexx Laboratories position peaked at $4K in Q1 2021.
  • 1,034 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2021.

Based on Wealthcare Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.